Melanocyte Stimulating Hormone, Beta (b-MSH)

Also known as: MSH BETA

Clinical Use

Use

The Melanocyte Stimulating Hormone, Beta (b-MSH) test measures Beta-melanocyte-stimulating hormone levels in the plasma. It is used primarily to assess endocrine function and may be useful in diagnosing and managing cases related to pituitary function, adrenal disorders, or other hormonal imbalances. As b-MSH is involved in various physiological processes, the test can aid in understanding its role in metabolic and cardiovascular functions as well as potential associations with other pathological conditions.

Special Instructions

Not provided.

Limitations

This test has been developed and its performance characteristics determined by Inter Science Institute, however, it has not been cleared or approved by the US Food and Drug Administration. Values obtained from different methods, laboratories, or kits may not be directly comparable, and should not be used interchangeably. Additionally, the results cannot be interpreted as absolute evidence of the presence or absence of malignant disease, requiring comprehensive clinical correlation for accurate interpretation.

Test Details

Methodology

Immunoassay (RIA)

Biomarkers

Melanocyte Stimulating Hormone, Beta

Analyte

Concentration / Level

Concentration / Level • Quantitative (Continuous) (e.g., copies/mL, % expression)

LOINC Codes

Order Codes

1950-5 - B-MSH SerPl-mCnc

Result Turnaround Time

15-20 days

Specimen

Plasma

Volume

3 mL

Minimum Volume

1 mL

Container

ARUP standard transport tube

Collection Instructions

Collect blood in a lavender (K2 or K3EDTA) or pink (K2EDTA) tube. Separate from cells immediately or within 2 hours of collection. Transfer specified volume to transport tube and freeze immediately.

Patient Preparation

Discontinue steroid, ACTH or hypertension medication, if possible, for at least 48 hours prior to collection. A morning fasting specimen is preferred.